Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK microdialysis of ertapenem and levofloxacin in diabetic foot infections
2007-001701-19Phase 4Active
- Sponsor
- CHU de Poitiers
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ertapenem and levofloxacin in diabetic foot infection (DFI) and foot ulcer, sponsored by CHU de Poitiers. Primary endpoint: Primary pharmacokinetic comparison of ertapenem and levofloxacin free concentrations in tissues and plasma. Started Sep 2007; status: active.
02
Drugs
ertapenemlevofloxacin
03
Conditions
diabetic foot infection (DFI)foot ulcer
Beyond the preview
Go deeper on 2007-001701-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001701-19.